Abstract
This manuscript has been removed because it included data obtained through a copyrighted questionnaire. The survey described in the manuscript was launched in haste during the pandemic and the authors were not aware of the copyright protection and acted in good faith. Attempts to obtain permission to use the questionnaire retrospectively were rejected by the copyright holders. The first author was not involved in the decision to include the copyrighted questionnaire, in any other aspects of the design of the survey or in the data collection and therefore bears no responsibility for this mishap. The senior author Anders Hviid takes full responsibility.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No specific funding was received for this work. The study was conducted as part of the governmental institution Statens Serum Institut's advisory tasks for the Danish Ministry of Health.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The details of the IRB/oversight body that provided approval or exemption for the research described are given below: This study was performed as a surveillance study as part of the governmental institution Statens Serum Institut's (SSI) advisory tasks for the Danish Ministry of Health. SSI's purpose is to monitor and fight the spread of disease in accordance with section 222 of the Danish Health Act. According to Danish law, national surveillance activities conducted by SSI do not require approval from an ethics committee. It was approved by the Danish Governmental law firm and SSI's compliance department that the study is fully compliant with all legal, ethical and IT-security requirements and there are no further approval procedures regarding such studies. Participation in the study was voluntary. The invitation letter to participants contained information about their rights under the Danish General Data Protection Regulation (rights to access data, rectification, deletion, restriction of processing, and objection). It was considered informed consent, if potential participants after having read this information decided to click on the link in the invitation, and fill-in the questionnaire.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Health data are considered person-sensitive, and cannot be shared due to data protection regulations.
